Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rajkondawar, Atul
NCT04449588 / 2020-001671-32: Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS	Terminated	2/3	369	Europe, RoW	BDB-001 Injection, Conventional treatment	Staidson (Beijing) Biopharmaceuticals Co., Ltd, Beijing Defengrui Biotechnology Co. Ltd	COVID-19 Pneumonia	03/24	03/24